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a b s t r a c t
The intracellular transport of Mason-Pﬁzer monkey virus (M-PMV) assembled capsids from the
pericentriolar region to the plasma membrane (PM) requires trafﬁcking of envelope glycoprotein (Env)
to the assembly site via the recycling endosome. However, it is unclear if Env-containing vesicles play a
direct role in trafﬁcking capsids to the PM. Using live cell microscopy, we demonstrate, for the ﬁrst time,
anterograde co-transport of Gag and Env. Nocodazole disruption of microtubules had differential effects
on Gag and Env trafﬁcking, with pulse-chase assays showing a delayed release of Env-deﬁcient virions.
Particle tracking demonstrated an initial loss of linear movement of GFP-tagged capsids and mCherry-
tagged Env, followed by renewed movement of Gag but not Env at 4 h post-treatment. Thus, while
delayed capsid trafﬁcking can occur in the absence of microtubules, efﬁcient anterograde transport of
capsids appears to be mediated by microtubule-associated Env-containing vesicles.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Intracellular targeting and transport of virus structural compo-
nents is critical to efﬁcient retrovirus replication. In most retro-
viruses, the nascent Gag polyproteins are transported directly to
the plasma membrane where assembly of the capsid shell and
membrane extrusion occurs simultaneously. Viruses that undergo
this form of type-C morphogenesis include the pathogenic human
viruses, human immunodeﬁciency virus and human T-cell leuke-
mia virus (HIV and HTLV-I, respectively). In contrast to type-C
morphogenesis, M-PMV, the prototypic type-D retrovirus, exhibits
spatial and temporal separation of capsid assembly, intracellular
transport and budding. The Gag polyprotein is ﬁrst targeted to an
intracytoplasmic pericentriolar site where capsid assembly occurs
(Choi et al., 1999; Sakalian and Hunter, 1999; Sfakianos et al.,
2003). An 18 amino acid sequence in the matrix domain (MA) of
Gag polyprotein, termed the cytoplasmic targeting/retention
signal (CTRS), is critical for directing intracytoplasmic assembly
of the MPMV immature capsids to the pericentriolar region,
through its interaction with the dynein light chain Tctex-1
(Vlach et al., 2008). A single amino acid change of arginine to
tryptophan (R55W) within the CTRS results in loss of this inter-
action and the switch of type-D morphogenesis to type-C mor-
phogenesis (Rhee and Hunter, 1990a, 1990b, 1991; Vlach et al.,
2008). Additional mutagenesis studies in this laboratory have also
shown that certain single or multiple amino acid changes within
MA can abrogate transport from the assembly site, redirect
budding to intracellular vesicles, block later stages of transport
or prevent capsid interactions with the plasma membrane (Rhee
and Hunter, 1991; Stansell et al., 2004, 2007).
While functional domains within the Gag polyprotein precur-
sor have been found to play important roles in capsid assembly
and intracellular transport, they invariably involve interactions
with multiple host cell components. Indeed, the site of M-PMV
capsid assembly, the microtubule organizing center (MTOC),
anchors a number of cellular components, such as the chaperonin
TRiC, that are involved in capsid assembly (Brown et al., 1996;
Hong et al., 2001). The MTOC also serves as a focal point of
interaction between M-PMV capsids and envelope glycoprotein
(Env), which along with components of the pericentriolar recy-
cling endosome, are required for efﬁcient export of preassembled
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Gag to the plasma membrane (Sfakianos and Hunter, 2003;
Sfakianos et al., 2003). In these previous studies, we demonstrated
that expression of a provirus lacking the env gene resulted in
accumulation of Gag in the pericentriolar region and a 7-fold
decrease in the kinetics of capsid release when compared to wild-
type. Furthermore, temperature block experiments that inhibit
vesicular trafﬁcking have suggested that Env-containing vesicles
may be required for transport of assembled capsids from the
pericentriolar region, and that this is dependent on a functional
recycling endosome. Mutations in Rab11 GTPase, an enzyme that
regulates recycling trafﬁcking, and the inhibition of membrane
tubule formation with the phospholipase A2 enzymes inhibitor
ONO-RS-082 both result in decrease in virion release (Sfakianos
and Hunter, 2003; Sfakianos et al., 2003; Ullrich et al., 1996).
Thus, while experimental studies to-date argue that passage of
Env through the recycling endosome is critical for efﬁcient M-PMV
virion release, details of intracellular capsid transport that occur
prior to release remain unclear. Although co-localization between
Gag and Env vesicles has been demonstrated in the pericentriolar
cytoplasmic region in ﬁxed cells, questions remain as to whether
these interactions are sustained to yield anterograde co-transport
of Gag and Env, or if Env facilitates the transfer of pre-assembled
capsids to an anterograde trafﬁcking network. Studies involving
protein structural analyses, yeast two-hybrid and GST pull-down
experiments have demonstrated that M-PMV Gag interacts
in a CTRS-dependent manner with cellular Tctex-1 (Vlach et al.,
2008), a light chain of the dynein motor complex, suggesting a
microtubule-dependent mode of retrograde transport of Gag to
the pericentriolar region for capsid assembly. In addition, utilizing
a green ﬂuorescent protein (GFP)-tagged Gag construct we have
obtained preliminary evidence that microtubules are involved in
intracellular transport of assembled capsids. Studies that have
explored the function of microtubules and plus-ended motors in
anterograde transport of various virus proteins (Hollinshead et al.,
2001; Jouvenet et al., 2004; Lee et al., 2006; Martinez et al., 2008;
Miranda-Saksena et al., 2000; Sathish et al., 2009; Suomalainen
et al., 1999) have demonstrated an absolute dependence on
this cytoskeletal network for virus trafﬁcking. Microtubule-
independent transport of viruses has, thus far, been reported
primarily for adenovirus proteins, and this movement is mostly
directed towards the cell nucleus (Glotzer et al., 2001; Yea et al.,
2007). In the current study, live cell imaging analysis provides, for
the ﬁrst time, direct evidence for intracellular anterograde co-
transport of M-PMV Gag and Env. Furthermore, a comprehensive
analysis of microtubules, actin and intermediate ﬁlaments by
live cell microscopy and/or pulse-chase biochemical experiments
demonstrate that Gag–Env co-transport and release is essentially
microtubule-dependent. However, novel and striking differences
in trafﬁcking and release patterns were observed for Gag and Env
following microtubule depolymerization, shedding light on the
nature of their interactions with host cell trafﬁcking components.
Results
Microtubule disruption causes a signiﬁcant decrease in the kinetics of
M-PMV production from CMMT cells
To evaluate the role of microtubules, actin ﬁlaments and IF in
intracellular transport of M-PMV, pulse-chase assays were per-
formed to determine how the disruption of one or more of these
cytoskeletal networks inﬂuences the kinetics of M-PMV transport
and release. An advantage of pulse-chase time course assays is that
Gag proteins can be tracked from the stages of synthesis and
assembly to the point of release. Furthermore, since M-PMV capsid
movement can be bidirectional, which we have detailed by live
imaging (Clark et al., in press), pulse-chase assays ensure that the
net direction of intracellular M-PMV capsid transport being
studied is indeed anterograde. As indicated by the experimental
outline in Fig. 1A, CMMT cells, chronically infected with M-PMV,
were pulse-labeled for 30 min with [35S]-methionine and then
chased in radiolabel-free media for 0, 2, 3, and 4 h. Cytoskeletal
inhibitors were added to CMMT cells at the beginning of the chase,
with 10 μM nocodazole, 2.5 μM cytochalasin D, or 5 mM acryla-
mide (ACR), being used to disrupt microtubules, actin ﬁlaments,
and IF, respectively. Immunostaining of ﬁxed CMMT cells with
rhodamine phalloidin and Alexa 488-conjugated anti-alpha tubu-
lin conﬁrmed the disruptive effects of cytochalasin D and noco-
dazole, with complete depolymerization of actin (Fig. 1B, left
panel) and microtubules (Fig. 1B, middle panel) being evident
after 4 h of treatment with these drugs. Immunostaining with
FITC-conjugated anti-vimentin (Fig. 1B, right panel) revealed
major alterations in IF organization after 4 h of ACR treatment,
which has been reported before (Durham, 1986; Grifﬁn et al., 1983;
Kumar et al., 2007). Treatment with ACR caused a collapse of
vimentin ﬁbers, leading to ﬁber bundling and a less extensive IF
network, as well as cell shrinkage and the formation of cell
retraction ﬁbers (white arrows, Fig. 1B, right panel). Importantly,
ACR treatment was also found to depolymerize actin ﬁlaments in
CMMT cells, which likely contributed to cell retraction (data not
shown). Similar effects were noted when cells were treated with
1% ββ′-iminodipropionitrile (IDPN), which is also commonly used
to disrupt IF (data not shown).
Cell lysates and culture media were collected from these drug-
treated cells and untreated controls at the indicated time points
during the chase. M-PMV Gag gene products from the collected
samples were immunoprecipitated as described in Materials
and methods section, subjected to SDS-PAGE and imaged using a
phosphor screen. The kinetics of Gag precursor processing was
determined by acquiring band intensities for Gag (Pr78), Gag–Pro
(Pr95), Gag–Pro–Pol (Pr180) and capsid (p27) and then calculating
the percentage of Pr78 and p27 relative to the sum of these
proteins at each time point (Fig. 2A, left panel). Data for untreated
cells are represented by the black line, while the blue, green and
red lines represent results for treatment with nocodazole, cyto-
chalasin D or ACR, respectively. Dual treatment with nocodazole
and ACR is indicated by the gray line. A comparison of virus release
at 2 h and 4 h during the chase was also performed by calculating
the ratio of Gag precursor proteins from pulse-labeled cells that
were shed as capsid protein (p27) (Fig. 2A, right panel). As shown
in the left panel of Fig. 2A, the half-life of Gag precursor processing
of Pr78 to p27 in untreated CMMT cells was 1 h 30 min. When
CMMT cells were treated with nocodazole after the pulse, a delay
of approximately 1 h was noted for the half-life, as compared
to the untreated control. A statistically signiﬁcant decrease
(p¼0.0027) in virion release was also noted after 2 h of nocoda-
zole treatment (Fig. 2A, right panel). Despite this initial delay, the
absolute levels of p27 continued to increase (Fig. 2A) and at later
time points during nocodazole treatment, were eventually found
to reach levels near those observed for untreated cells.
In contrast to what was observed for nocodazole-treated cells,
treatment with cytochalasin D had a negligible effect on the kinetics of
Gag processing. The effects of ACR treatment, which disrupt both IF
and actin ﬁlaments, were also minimal but a 30min delay in Gag
precursor processing was noted when compared to untreated and
cytochalasin D-treated CMMTcells (Fig. 2A). Differences in the levels of
virion release are also evident in the autoradiographs in Fig. 2B which
illustrates p27 protein immunoprecipitated from chase culture media
and cell lysates during treatment with the indicated cytoskeletal
inhibitors. For purposes of clarity, only p27 bands from each set of
untreated or treated CMMT cells are shown, and these were digitally
re-assembled without modiﬁcation to better indicate p27 levels at
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Fig. 1. Cytoskeleton disruption in CMMT cells. (A) Schematic of pulse-chase assay (quantitated in Fig. 2) illustrating the timing of treatment with cytoskeleton-disrupting
drugs during the chase. (B) Immunoﬂuorescence microscopy conﬁrming disruption of actin ﬁlaments (left panel), microtubules (middle panel) and IF (right panel) after 4 h
of treatment with 2.5 μM cytochalasin D, 10 μM nocodazole, or 5% ACR, respectively. Bar¼15 μm.
Fig. 2. Effect of microtubule, actin or IF disruption on the kinetics of Gag precursor processing and virion release. CMMT cells were metabolically labeled with [35S]
methionine and then chased for 0, 2, 3, and 4 h in the absence or presence of indicated drugs. (A) Data shown illustrates the molar percent of Pr78 and p27 at each time point
(left panel) from untreated cells (black lines) or those treated with cytochalasin D (green lines), nocodazole (blue lines), ACR (red lines) or nocodazole and ACR (gray lines),
which were added at the beginning of the chase. The right panel indicates the molar ratio of p27 that was released at 2 h (gray bars) and 4 h (black bars) after the indicated
drug treatments. The stars indicate a signiﬁcant statistical difference of po0.05 (paired t-test) when compared to the untreated control. (B) Time-course autoradiographs
illustrating p27 capsid protein released from untreated cells or those treated with indicated drugs. Data shown is representative of ﬁve independent assays.
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speciﬁc time points. It is important to note that while levels of both
cell-associated (cell lysates) and cell-free (culture media) capsid
protein are shown here, the sum of these p27 levels is used in
quantitative analyses as a more accurate indicator of capsid release,
since previous studies have shown that cleavage of Gag requires
particle budding and release from the cell. Interestingly, when all
three cytoskeleton networks were simultaneously compromised
using a combination of nocodazole and ACR (or IDPN), Gag
processing and virion release from CMMT cells still occurred at
the reduced rates observed for CMMTcells treated with nocodazole
alone (Fig. 2A and B). Of note, similar results were obtained from
pulse-chase assays utilizing the alternative cytoskeleton inhibitors,
taxol and latrunculin B, which stabilizes microtubules and depoly-
merizes actin ﬁlaments, respectively (data not shown), conﬁrming
that our observations are the result of disruptive effects on these
speciﬁc cytoskeletal components. A leaky release of virions from
the cytoplasm due to possible side effects of these drug treatments
on the integrity of the plasma membrane is unlikely, since as
described above efﬁcient Gag precursor processing to p27 by the
viral protease can only occur when the capsid undergoes comple-
tion of the budding process (Parker and Hunter, 2001; Yasudo and
Hunter, 1998). Thus, in summary, the most pronounced effects on
Gag processing and virus output involved microtubule disruption,
although virus release still occurred, albeit at a delayed rate, in the
absence of three major functional cytoskeletal networks.
M-PMV virions released from nocodazole-treated CMMT cells lack
Env
Since the most pronounced effect on M-PMV Gag release was
observed following microtubule disruption, a pulse-chase assay was
also performed to determine the effects on Env after nocodazole
treatment. Since Env precursor Pr86 and its processed protein
products gp70, gp22 and gp20 all have relatively low methionine
content, [3H]-leucine was utilized for efﬁcient radiolabeling of these
proteins. M-PMV Gag and Env proteins were then immunoprecipi-
tated from pulse cell lysates, 5 h chase cell lysates and chase culture
media with a goat anti-M-PMV polyclonal antibody as described
in Materials and methods section. As shown in Fig. 3, the level of
the Env protein products gp70 and gp20 in virions released from
nocodazole-treated cells is signiﬁcantly reduced when compared to
the level of Env in virions released from the untreated control. The
band, with a molecular mass of 78 kDa that is observed in the chase
media from nocodazole-treated cells is residual Gag Pr78, which is
also detected in COS-1 cells expressing an env-gene deleted M-PMV
provirus (Fig. 3, right panel). Quantitation of the radioactivity asso-
ciated with the region of the gel encompassing gp70 demonstrated a
more than 60% reduction in area under the curve for virions from
nocodazole treated cells, although again the sharpness of the peak is
consistent with this residual radiolabel being in Pr78 (Supplementary
Fig. 1). Analysis of the levels of Env precursor Pr86 in the CMMT chase
cell lysates, showed increased intensity in this band in treated cells,
consistent with a two- to three-fold decrease in Env processing in the
presence of nocodazole. In addition, a small increase in the intensity of
gp70 and gp22 was observed in treated cells (Fig. 3, chase lysates),
suggesting that whatever precursor was cleaved remained cell asso-
ciated. The disruption of actin or intermediate ﬁlaments had negligible
effects on Env processing and release (data not shown).
Live cell imaging of nocodazole-treated CMMT cells reveals a loss in
linear movement of M-PMV Gag and Env
Although results from the pulse-chase assays provide strong
evidence for a predominant, but non-essential, role for microtubules
Fig. 3. Microtubule disruption leads to a deﬁciency in Env incorporation in released virions. Autoradiography of CMMT cells that were metabolically labeled with [35H]
leucine for 30 min and chased in non-radioactive media for 5 h with or without nocodazole. Indicated are the major Gag precursors Pr78 and Pr95 and the processed product
p27, and the Env precursor Pr86 and its processed products gp70, gp22 and gp20. To better illustrate Pr86, lysates of COS-1 cells that were transfected with a ΔEnv plasmid
construct are also shown. Data shown is representative of three independent experiments.
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in M-PMV capsid release, this approach does not deﬁne the actual
effect on intracellular capsid transport over the course of nocodazole
treatment. In addition, it provides no indication of whether virion
release is the result of co-transport or independent trafﬁcking of Gag
and Env. Live cell microscopy experiments were therefore performed
to gain a real time perspective of capsid and Env movements before
and during nocodazole treatment. Using live-cell microscopy,
M-PMV-producing CMMT cells were visualized in real time approxi-
mately 7 h post-transfection with a plasmid construct expressing
codon-optimized M-PMV Gag–GFP (pSARM–GagGFP–M100A; Clark
et al., in press). Analysis at this early time point allows for a balance
between the level of detectable GFP signal and the number of Gag–
GFP particles that is statistically relevant for velocity measurements.
Visualization at this time point also increases the likelihood that the
observed ﬂuorescent capsids are newly synthesized and are not
endocytosed particles. M-PMV capsids containing Gag–GFP were
observed as dynamic green ﬂuorescent puncta, with many exhibit-
ing plus-ended movement towards the cell periphery (Movie S1). In
cells that were co-transfected with plasmids expressing Gag–GFP,
andmCherry fused to the microtubule subunit tubulin, a few distinct
Gag–GFP particles were observed to move linearly along microtu-
bules that were visible as red dynamic tubular structures (Movie S1,
Supplementary Fig. 2). As we described previously (Clark et al., in
press), bidirectional movement and occasional stalling of Gag–GFP
particles was often noted, which is typical for microtubule motor-
based movement given that switching of cargo between minus- and
plus-ended motors tends to occur (Hendricks et al., 2010; Ross et al.,
2008; Shah et al., 2000). These data are thus consistent with the
pulse-chase experiments suggesting a role for microtubules in
capsid transport. In contrast, live imaging of CMMT cells stained
with actin-RFP and transfected with the plasmid expressing Gag–
GFP revealed a lack of linear movements along actin ﬁlaments,
suggesting limited utilization of this cytoskeletal network for long
range transport (Movie S2), which is also in agreement with results
from the pulse-chase experiments.
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.virol.2013.11.006.
Imaging was then performed on CMMT cells co-transfected
with plasmids expressing Gag–GFP and Env–mCherry before and
during nocodazole treatment. Cells were imaged every 5 s for a
total of 2 min. As shown in Movie S3, in addition to the green Gag–
GFP and red Env–mCherry particles that were observed to exhibit
movement independent of each other, a large fraction of yellow,
co-localized Gag–Env puncta were observed, illustrating, for the
ﬁrst time, intracellular co-transport of Gag and Env. To assess the
pattern of the path taken by these particles, their movement in
untreated CMMT cells was tracked using the ImageJ plug-in
MTrackJ, which allows for individual particle tracking. Only parti-
cles that exhibited movement towards or near the plasma mem-
brane were considered. In general, the Env-containing vesicles
with associated Gag (yellow) exhibited long, linear trajectories,
while the individual Gag–GFP (green) and Env–mCherry (red)
puncta, exhibited similar but shorter trajectories (Movie S3 and
Fig. 4A, left panel). The movement of some of each type of particle
was also observed to be bi-directional.
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.virol.2013.11.006.
When cells were monitored 2 h after nocodazole treatment,
a dramatic effect on intracellular movement was observed and
linear tracks were essentially absent for all particles (Movie S4 and
Fig. 4A, middle panel). Thus, an intact microtubule network is
critical for intracellular trafﬁcking at this time after initiation of
nocodazole treatment. Surprisingly, after 4 h of nocodazole treat-
ment, movement of a majority of Gag–GFP particles was again
evident, as shown by the green tracks (Movie S5 and Fig. 4A, right
panel). The movement of these Gag–GFP particles was non-linear
and was found to occur throughout the cell, including the periphery.
In sharp contrast, this was not the case for Env–mCherry and co-
localized Gag–Env vesicles, which remained static at this later time
point. Given that Env-containing vesicles would be predicted to move
linearly exclusively on microtubules, this observation conﬁrms
microscopic evidence that microtubules remained depolymerized at
this time.
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.virol.2013.11.006.
To further characterize particle movement, the velocity of Gag–
GFP, Env–mCherry and Gag–Env vesicles in untreated cells (n¼5)
and cells treated with nocodazole for 2 h (n¼5) and 4 h (n¼5) was
calculated, also using MTrackJ. As shown in Fig. 4B, Gag–GFP
particles in untreated cells exhibited a median maximum velocity
of approximately 0.5 μm/s, which is within the range of what
has been previously described for microtubule-based movement
(Bremner et al., 2009; Gazzola et al., 2009; Lee et al., 2006). While
this velocity decreased substantially (at least ﬁve-fold) to less than
0.1 μm/s in cells treated with nocodazole for 2 h, a signiﬁcant
(po0.0001) three-fold recovery to a median velocity of approxi-
mately 0.3 μm/s was observed in cells after 4 h of nocodazole
treatment. This recovered movement, however, has a signiﬁcantly
lower (po0.0001) median velocity in the 4-h nocodazole-treated
cells compared to what is observed in untreated cells. In contrast,
Env–mCherry particles and co-localized Gag–Env particles in
untreated CMMT cells initially demonstrated median maximum
velocities of 0.5 μm/s and 0.6 μm/s, respectively, that was reduced
to o0.1 μm/s upon nocodazole treatment, but did not exhibit any
recovery in velocity after nocodazole treatment at the 4 h time
point, which is consistent with the particle track patterns visualized by
live imaging. To account for cell-to-cell variability, single cell analysis
was also performed inwhich Gag–GFP particle movement in the same
cell was monitored pre- and post-treatment with nocodazole. Results
obtained were similar to those observed for the multi-cell analysis
described above (data not shown), and importantly the observed
changes in the velocity and track patterns of Gag–GFP, Env–mCherry
and Gag–Env particles during nocodazole treatment are in agreement
with results acquired from the pulse-chase assays described above,
which demonstrated a delay in Gag release and also a lack of Env
incorporation in released M-PMV capsids. Similar imaging experi-
ments performed for cytochalasin D-treated cells and ACR-treated
cells revealed no signiﬁcant changes in capsid velocities, though it
should be noted that treatment with these drugs distorted cell
morphology substantially, therefore making it difﬁcult to accurately
monitor capsid movement in live cells (data not shown).
M-PMV capsid movement in 4 h nocodazole-treated CMMT cells
appears to utilize a directed mode of transport
Since our results demonstrated a clear, albeit staggered and
short-range movement of M-PMV capsids containing Gag–GFP
after 4 h of nocodazole treatment, it was important to deﬁne
whether this motion was random diffusion in the cytoplasm
or directed transport. A property of particle movement that is
commonly utilized for this purpose is mean squared displacement
(MSD), which is the average distance a given particle travels in a
deﬁned period of time. Importantly, it takes into account the
distance that is traveled relative to the particle's starting position,
thereby helping to distinguish between random and productive
movement. To obtain MSD values, particle trajectories were ﬁrst
generated using the ImageJ plug-in Particle Detector and Tracker,
which allows for the automated and simultaneous selection of
multiple ﬂuorescent particles in live cells, based on user-deﬁned
parameters, as described in Materials and Methods section.
Trajectories were generated for randomly selected particles
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(n¼20) for each group of untreated CMMT cells (n¼4) and 4 h
nocodazole-treated cells (n¼5), and the MSD for each time
interval (Δt) within the trajectory was calculated (see Materials
and methods section). Using these values, curves relating MSD to
time were generated for each of the 40 total particle trajectories.
A typical particle trajectory and corresponding graph is illustrated
in Fig. 5A. Separation of the curve into phases indicates a change in
the type of movement over the course of the trajectory. Once
converted to a log–log scale (Fig. 5B), the slope of each phase
confers a numerical value to the type of movement, with values of
1 representing Brownian motion, and values 41 or o1 indicating
directed and obstructed movement, respectively. Typically, values
within a window of 0.9–1.1 are considered to exhibit Brownian
motion, with values greater than 1.1 suggesting active transport
(Forest et al., 2005). By utilizing this method, the collective
analyses of trajectory phases of particles (n¼20) in 4 h
nocodazole-treated cells revealed that the movement of the
majority (60%) of Gag–GFP labeled capsids involved a directed
mode of transport, which was similar to what was observed for
particle trajectories (n¼20) in untreated CMMT cells (Fig. 5C). The
median MSD of Gag–GFP particles in 4 h nocodazole-treated cells
is not statistically signiﬁcant from the upper MSD value that
denotes Brownian motion, and so this form of movement cannot
be entirely ruled out. However, as evidenced by the particle tracks
in Fig. 4A and Movie S4, the pattern of Gag–GFP movement in
nocodazole-treated cells after 2 h is distinctly different from the
patterns observed after 4 h of nocodazole treatment (Fig. 4A and
Movies S4 and S5), despite the fact that Brownian motion would
Fig. 4. Nocodazole treatment leads to a transient decrease in linear movement of intracellular capsids. CMMT cells were co-transfected with pSARM–GagGFP–M100A and
pTML-Env–mCherry and visualized in real time with a Deltavision deconvolution microscope. Live imaging of untreated cells and those treated with nocodazole for 2 h and
4 h was performed. Videos were recorded over a 2 min time period, with each video having an identical frame rate of ﬁve frames per second. (A) Illustration of tracks for
Gag–GFP (green), Env–mCherry (red) and co-localized Gag–Env particles (yellow) in untreated and nocodazole-treated cells. Tracks shown are for particles moving towards
or near the plasma membrane, with arrow heads indicating direction of movement. Data shown is representative of at least ﬁve independent imaging experiments.
Bars¼15 μm. See accompanying Movies S2–S4 for real time visualization of particle tracking. (B) Maximum velocity measurements of Gag–GFP particles (nZ15), Env–
mCherry particles (nZ10) and co-localized Gag–Env particles (nZ23) in untreated cells and nocodazole-treated cells after 2 h and 4 h of drug treatment. A minimum of
5 cells was analyzed at each time point. Bars indicate median values. Statistical signiﬁcance is denoted by p value or ns (not signiﬁcant).
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occur at both time points. These observations together with the
MSD analyses, collectively suggest that the movement of Gag–GFP
particles after 4 h of nocodazole treatment is directed to some
degree.
Discussion
The aim of current study was to elucidate whether previously
reported pericentriolar interactions between M-PMV Gag and
Env-containing recycling vesicles are maintained as stable co-
transported entities towards the plasma membrane or if these
interactions simply facilitate the transfer of Gag to an anterograde
trafﬁcking system. It was also necessary to elucidate whether this
(co-)transport occurs via a cytoskeleton-dependent network. This
study involved a real time approach using time-course pulse-chase
assays and live-cell imaging experiments, to monitor the kinetics
of M-PMV capsid transport over extended periods of time. Doing
so provided insight into dynamic M-PMV-host interactions, by
helping to identify cytoskeletal factors involved in anterograde
intracellular transport, and shedding light on the extent to which
these factors are required by M-PMV.
For the ﬁrst time, live cell imaging provides direct evidence
that the interactions between Gag and Env are not short-lived,
with clear co-localization and sustained anterograde co-transport
of Gag–Env particles being observed in CMMT cells. A beneﬁt of
utilizing CMMT cells for these studies is that endogenous Gag or
Env that is constitutively produced by the cells allows for normal
assembly of GFP-labeled capsids and mixed trimers (Salzwedel
and Berger, 2009) of wild-type and mCherry-labeled Env. Thus,
it is possible that a fraction of ﬂuorescent-tagged Gag particles are
associated with endogenous Env, and vice versa. Indeed, the
similar median velocities of Gag–GFP, Gag–Env and Env–mCherry
particles in untreated CMMT cells may reﬂect this. However, there
was a signiﬁcant difference between the velocities and patterns of
movement of Gag–GFP versus Gag–Env or Env–mCherry particles
after 4 h of nocodazole treatment, and the overall consistency of
the live imaging and pulse-chase results lend validity to the
differential transport and release patterns observed for Gag
and Env.
The data collectively demonstrate that the intracellular trans-
port of Env and Gag–Env co-localized vesicles, and subsequent
release of Env are critically dependent on the presence of micro-
tubules. While efﬁcient intracellular transport of Gag also primarily
depends on this cytoskeletal network, a unique and unexpected
ﬁnding from our results was that the effect of microtubule disruption
on capsid transport was only temporary, with nocodazole-treated cells
exhibiting an initial two-fold reduction in Gag processing and release
but later showing levels of Gag release that were near those observed
for untreated cells. However, released virions lacked Env and these
observations were strongly supported by accompanying live imaging
results.
The observed movement and release of Gag in the absence of
microtubules is likely to include a combination of factors that are
secondary to the disruption of the MTOC by nocodazole. While
a role for alternate cytoskeletal pathways in nocodazole-treated
cells could not be conﬁrmed by live imaging due to the shrinking
morphological effects of CytD and ACR, biochemical pulse-chase
assays suggest that actin and/or intermediate ﬁlaments play a
minimal role in facilitating the release of Gag in the absence of
microtubules. Furthermore, live imaging of untreated CMMT cells
stained with actin-RFP and transfected with a plasmid expressing
Gag–GFP failed to demonstrate linear movement of Gag–GFP
particles on actin ﬁlaments (data not shown). This is in sharp
contrast to the distinct linear tracks observed for Gag–GFP on
mCherry-labeled microtubules. However, these ﬁndings do not
rule out a role for the dense cortical actin network, which may
facilitate short-range movement of capsids when proximal to the
plasma membrane.
The movement of Gag–GFP particles that was observed in
nocodazole-treated cells after 4 h appeared to be distributed
throughout the cell, and was typically short-range and staggered
in nature, as demonstrated by particle tracking. In sharp contrast,
Env–mCherry vesicles and Gag–Env co-localized vesicles were
visibly static throughout these treated cells. This is further high-
lighted by the difference in velocity of Gag–GFP particles when
compared to Gag–Env and Env–mCherry particles after 4 h of
nocodazole treatment (p value o0.0001). As illustrated by the
model in Fig. 6, the loss in spatial proximity of nascent or pre-
existing Env or Env–mCherry with recycling endosomal vesicular
compartments due to MTOC disruption, and a cessation in vesi-
cular trafﬁcking due to microtubule depolymerization likely
contributed to the stagnant nature of Env–mCherry and Gag–Env
particles in nocodazole-treated cells. These data, together with
Fig. 5. MSD analysis of intracellular capsid movement after long-term nocodazole
treatment. (A) Representative particle trajectory and accompanying MSD graph
with separated phases I–III indicated. Conversion of this graph to a log–log scale is
shown in (B), with calculated slope values indicating a different mode of movement
for each phase of the trajectory. (C) Analysis of MSD of Gag–GFP trajectories (n¼20
per group) in untreated cells (n¼4) and cells treated with nocodazole (n¼4) for
4 h. Solid bars indicate median slope values for each group of cells, with dotted
lines relating slope values to the type of particle movement.
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the pulse-chase assay results showing a lack of Env in released
particles, strongly suggest an absolute dependence of Env-
containing recycling vesicles on microtubules, and by extension,
an inability of Env to utilize other secretory or vesicular trafﬁcking
pathways that are microtubule-independent.
Collectively, the differential effects on Gag and Env transport
following microtubule depolymerization also argue against the
regeneration and/or presence of nocodazole-resistant microtu-
bules. While nocodazole-resistant microtubules composed of
detyrosinated tubulin have been reported, their stability persists
for only short term nocodazole-treatment, with treatments greater
than 1–2 h leading to their complete depolymerization (Quinones
et al., 2011). Indeed, immunostaining with an antibody targeting
detyrosinated tubulin in CMMT cells demonstrated a complete loss
of these microtubules after 4 h of nocodazole treatment (data not
shown).
The observed albeit inefﬁcient movement of Gag–GFP particles
after long-term nocodazole treatment was likely a combination of
existing Gag-particles, and nascent Gag–GFP synthesized from
dispersed polysomes (Fig. 6). However, results from the pulse-
chase experiments, which track the fate of radiolabeled proteins,
suggest that Gag that was synthesized prior to the addition of
nocodazole was eventually released 4 h after microtubule depoly-
merization. The fact that Gag–GFP particles exhibited some degree
of movement, unlike the static nature of both Env–mCherry and
Gag–Env vesicles as shown by live imaging, suggest that the motile
Gag/Gag–GFP particles at the 4 h time point were not associated
with Env vesicles.
The staggered movement of Gag–GFP particles over limited
distances may have been the result of stochastic unstable interac-
tions with microtubule-independent trafﬁcking components,
or reﬂective of Brownian motion. The median MSD of Gag–GFP
particles in 4 h nocodazole-treated cells suggested that the move-
ment was active in nature, and given that a notable level of virion
release was observed at this time point, it was likely the result of
directed motion. However, the MSD value was not statistically
signiﬁcant from the range that denotes Brownian motion and so it
is not improbable that both forms of movement are occurring to
some degree. These irregular movements and/or transient inter-
actions, particularly in the cell periphery, may have been sufﬁcient
to facilitate capsid release.
The possibility of capsid assembly occurring directly at the
plasma membrane also cannot be discounted. Random molecular
interactions and inefﬁcient staggered movements of Gag may
occur even in the presence of microtubules, and a minimal release
of non-viable Env-deﬁcient capsids from untreated cells is not
implausible. Indeed, it should be noted that while short non-linear
particle tracks were exhibited by the majority of Gag–GFP particles
in nocodazole-treated cells, a similar pattern was also observed
for a minor population of Gag–GFP particles in untreated cells.
However, it is clear that although microtubules are not critical for
Gag transport and release, the alternative pathway(s) that is
utilized does not yield functional Env-containing virions, high-
lighting the importance of the interdependent relationship
between Gag and Env.
The sustained co-localization of Gag–GFP and Env–mCherry
that was observed as highly motile or stagnant particles in
untreated and nocodazole-treated cells, respectively, suggests that
Env is important for mediating a stable interaction between Gag
and the Env-containing recycling vesicles. It is currently unclear if
this is solely a direct Env–Gag interaction, or if interactions with
Env trigger conformational changes in Gag that allow it to dock on
to the recycling vesicle. Further support for an Env-mediated
interaction is derived from previous studies in which cells expres-
sing M-PMV provirus with an env deletion exhibited a 7-fold
decrease in Gag release, despite the presence of microtubules and
a functional recycling vesicular trafﬁcking network.
Interestingly, the results from the pulse-chase experiments
demonstrated continued release of M-PMV Gag even when all
three cytoskeleton components were compromised. In addition,
earlier studies involving the PLA2 inhibitor ONO-RS-082 prompted
the suggestion of a membrane tubule-vesicular means of transport
(Sfakianos and Hunter, 2003; Sfakianos et al., 2003; Ullrich et al.,
1996). These observations prompted an evaluation of a cytoskele-
ton-independent, membrane tubule-based transport network.
However, live imaging experiments of untreated cells,
Fig. 6. Model illustrating anterograde co-transport of M-PMV Env and Gag on recycling vesicles. In the presence of microtubules (MT) and the microtubule organizing center
(MTOC), capsid assembly from Gag-translating polysomes occurs at the pericentriolar region. Env, which trafﬁcs through the recycling endosome (RE), mediates a stable
interaction between pre-assembled capsids and RE-derived vesicles to facilitate anterograde linear transport on MT to the plasma membrane (PM). Nocodazole treatment
results in a loss of MT and a dispersal of MTOC organelles, resulting in Gag synthesis and capsid assembly throughout the cell, including the periphery. The recycling,
transport and release of Env, which rely on vesicular transport, cease due to a dependence of recycling vesicles on MT. Capsid release continues to occur at an inefﬁcient rate
due to stochastic movements and/or interactions of Gag with cortical actin ﬁlaments (AF) or microtubule-independent transport/secretory vesicles. Capsid assembly may
also occur directly at the PM, leading to the release of non-infectious Env-deﬁcient virions.
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nocodazole-treated cells, and cells treated with BFA which induces
membrane tubule formation, all failed to show productive linear
movement
of Gag–GFP along or on these membrane tubular structures, with
only transient interactions being observed (data not shown).
Furthermore, live imaging of CMMT cells treated with ONO-RS-
082, which inhibits tubule formation, revealed that despite a dose-
dependent block in virion release, intracellular movement of Gag–
GFP was still evident (data not shown), suggesting differential
effects of this compound on transport and release. This is not
entirely surprising given that the PLA2 superfamily of enzymes,
which are also involved in the generation of membrane curvature,
are likely to inﬂuence the formation and release of budding
vesicles. Thus, intracellular (co-)transport of Gag and Env is
unlikely to be cytoskeletal-independent. This is further supported
by studies that have demonstrated that the elongation and/or
movement of membrane tubule structures also require a func-
tional cytoskeletal network.
In summary, live cell imaging has for the ﬁrst time deﬁnitively
demonstrated intracellular anterograde co-transport of M-PMV
Gag and Env in real time. Results have further shown that the co-
localization of Gag and Env vesicles is stable and sustained during
transport, and that this interaction is primarily mediated by Env,
which is consistent with previous ﬁndings (Sfakianos and Hunter,
2003; Sfakianos et al., 2003; Ullrich et al., 1996). Importantly, the
novel differential effects on Gag and Env transport and release
following microtubule depolymerization, as shown by live imaging
and biochemical pulse chase assays, highlight an absolute depen-
dence of Env-containing vesicles, and by extension the associated
Gag, on microtubule-based transport. It will be of interest to map
the molecular and structural determinants that shape the speci-
ﬁcity of Env for recycling vesicles and its interaction with Gag. It is
important to note that while microtubules appear to be partially
dispensable for Gag transport and capsid release, the alternative
pathway(s) is not viable for the production of Env-containing
virions (Fig. 6). Nonetheless, identifying and characterizing traf-
ﬁcking factors that facilitate short-range Gag transport, in the
presence and absence of microtubules, will help deﬁne distinct
genres of intracellular trafﬁcking pathways and may reveal a
broader scope of interactions between Gag and host cell transport
factors.
Methods
Cell lines and reagents
CMMT cells, originally established by co-cultivating rhesus
mammary tumor cells with rhesus monkey embryo cells, actively
produce infectious M-PMV. COS-1 cells, derived from the African
green monkey kidney cell line, CV-1, by transformation with an
origin-defective mutant of SV40 (Gluzman, 1981) were obtained
from the American Type Culture Collection. These cells were
cultured in Dulbecco's modiﬁed Eagle's medium (DMEM) supple-
mented with 10% fetal bovine serum, 2 mM L-glutamine, 100 U
penicillin G/ml and 100 μg/ml streptomycin sulfate (all from
Gibco). The cell line was maintained at 37 1C in a 5% CO2 incubator.
Stock solutions of the cytoskeletal disrupting agents (Sigma) were
prepared in dimethyl sulfoxide (DMSO) and diluted 41000-fold in
culture medium for experiments. Cytochalasin D was used at a
ﬁnal concentration of 2.5 μM to depolymerize actin ﬁlaments, and
10 μM of nocodazole and 5 mM ACR was used to disrupt micro-
tubules and intermediate ﬁlaments, respectively. For untreated
controls, DMSO that was diluted to identical levels was added
to cells.
Plasmid constructs
To facilitate live cell imaging studies, plasmid constructs in
which M-PMV Gag and Env were fused to GFP and the red
ﬂuorescent protein mCherry, respectively, were co-transfected into
CMMT cells. Brieﬂy, pSARM–GagGFP–M100A is a proviral con-
struct containing a Kozak-optimized ribosomal start site, an
M100A amino acid substitution, and a gag–egfp fusion replacing
the pro and pol genes. The plasmid pTML–Env–mCherry is a
derivative of the pTMO construct (Brody et al., 1994), and contains
the M-PMV env gene under transcriptional control of the myopro-
liferative sarcoma virus LTR, with mCherry fused to the cytotail of
Env via a six amino acid linker. A second Env–mCherry fusion
construct, pSARMX–EnvCherry, was generated by PCR cloning of
PPQISPP–mcherry–PPSIQPP into the env gene of the plasmid
pSARMX, just upstream the membrane-spanning domain of Env.
This second construct behaves and localizes comparably to the
pTML–Env–mCherry plasmid used in this manuscript, and is
incorporated into virions, which was conﬁrmed by sucrose density
gradient analysis (manuscript in preparation).
Antibodies and staining reagents
In pulse-chase assays, M-PMV Gag was immunoprecipitated
with polyclonal rabbit anti-p27CA antibody (1:1000). For detection
of Env and Gag, goat anti-M-PMV polyclonal antibody (1:1000)
was utilized as previously described (Stansell et al., 2007). For
immunostaining of cytoskeleton networks in ﬁxed CMMT cells,
rhodamine phalloidin and anti-alpha tubulin mouse monoclonal
antibody (Invitrogen, Carlsbad, CA), were utilized to detect actin
ﬁlaments and microtubules, respectively. To detect intermediate
ﬁlaments, cells were immunostained with FITC-conjugated anti-
vimentin monoclonal antibody (eBioscience, San Diego, CA).
Immunoﬂuorescence microscopy
CMMT cells expressing M-PMV provirus were grown as mono-
layers on 22-mm glass coverslips and immunostained 15 h after
seeding. For immunostaining of actin and intermediate ﬁlaments,
cells were ﬁxed with 4% paraformaldehyde for 20 min, permeabi-
lized using 0.1% Triton X-100 for 10 min and blocked with Dako
blocking reagent (Dako, Carpinteria, CA) for 10 min, all at room
temperature. Dyes and/or antibodies speciﬁc for these cytoskeletal
networks were diluted in Dako antibody diluent and added to cells
according to manufacturer's protocols. Immunostaining of micro-
tubules was performed in similar manner, with the exception of
CMMT cells being ﬁxed with a mixed solution of 3.75% PFA and
0.25% gluteraldehyde. After washing twice with 1 PBS, cover-
slips were mounted in ProLong antifade reagent (Invitrogen)
containing DAPI for nuclei staining. Cells were visualized using a
60 oil objective on a Deltavision deconvolution ﬂuorescence
microscope (Applied Precision Inc., Issaquah, WA). Images were
acquired and processed using Deltavision SoftWoRx software
(Applied Precision Inc., Issaquah, WA).
Metabolic labeling and immunoprecipitation of M-PMV proteins
CMMT cells were pulse-labeled as described previously
(Stansell et al., 2007). Brieﬂy, cells were starved for 15 min in
methionine- and cysteine-deﬁcient DMEM and then pulse-labeled
for 30 min with 100 μCi of [35S]methionine–[35S]cysteine protein-
labeling mix (Perkin-Elmer NEN, Boston, MA). Cells were then
washed and chased in complete DMEM media for 2, 3 or 4 h.
Where indicated, cytochalasin D, nocodazole or ACR was added to
cells immediately at the beginning of the chase (4 h treatment).
Pulse and chase cell lysates and chase culture media were
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collected and processed as described previously (Stansell et al.,
2007). Viral proteins were immunoprecipitated from cell lysates
and culture media samples using polyclonal rabbit anti-p27CA
antibody and then separated by SDS-polyacrylamide gel electro-
phoresis. SDS-PAGE gels were dried and exposed to phosphor
screens, and then visualized and quantiﬁed using the Packard
CycloneTM phosphor imaging software OptiQuant (Perkin-Elmer,
Shelton, CT). Further quantiﬁcation to determine the molar per-
centage or molar ratios of Gag precursor Pr78 and p27 capsid at
each time point were calculated as described previously (Stansell
et al., 2007). For optimal detection of M-PMV Env, a similar assay
was performed with the exception that cells were pulse-labeled
with [3H]-leucine and lysed using 1% Triton X-100 lysis buffer (1%
Triton X-100, 0.05 M NaCl, 0.025 M Tris, pH 8.0) instead of 1% SDS.
Viral proteins in cell lysates and culture media from this assay
were immunoprecipitated with polyclonal goat anti-M-PMV anti-
body. SDS-PAGE gels were treated with En3hance as per manufac-
turer's protocol (Perkin-Elmer, Waltham MA) and then exposed
to autoradiography ﬁlms for at least 5 days at 70 1C before
development.
Live cell imaging
CMMT cells transfected with pSARM–GagGFP–M100A were
visualized in real time at 6–8 h post-transfection using the
Deltavision deconvolution microscope. Cells co-transfected with
pSARM–GagGFP–M100A and pTML–Env–mCherry were imaged at
15–18 h post-transfection due to delayed expression of the Env–
mCherry signal. For imaging capsid movement along microtu-
bules, CMMT cells were co-transected with pSARM–GagGFP–
M100A and p-mCherry–tubulin, and imaged 15–18 h post-
transfection. To image capsids and actin ﬁlaments, cells were
transduced with CellLights actin-RFP (Life Technologies, Carlsbad,
CA) followed by transfection with pSARM–GagGFP–M100A and
imaged 6–8 h post-transfection. During imaging, live cells were
kept in a CO2-permeable microchamber maintained at a tempera-
ture of 37 1C. Videos were acquired for untreated CMMT cells and
for those treated with nocodazole for 2 h and 4 h. Similar imaging
was performed for cells treated with cytochalasin D or ACR for 4 h.
For each video, images were acquired across ﬁve z-stacks every 5 s
over a total 2 min time period. The quick projection feature of the
Deltavision SoftWorx software was utilized to process all videos to
generate identical output frame speeds of ﬁve frames per second.
Video analysis
Particle tracking and velocity measurements were performed
using the ImageJ (http://rsbweb.nih.gov/ij/) software plug-in
MTrackJ (E. Meijering, Biomedical Imaging Group Rotterdam, Neth-
erlands). Statistical analysis of velocity measurements was per-
formed using the Mann-Whitney non-parametric t-test. A p value
of less than 0.005 was considered to be statistically signiﬁcant. To
determine mean squared displacement, trajectories were generated
for multiple randomly selected Gag–GFP particles in untreated
CMMT cells and those treated with nocodazole for 4 h, using the
ImageJ plug-in Particle Detector and Tracker (Sbalzarini and
Koumoutsakos., 2005). The trajectories were ﬁltered to only include
those that contained at least 12 time points. The x/y coordinates of a
particle at each time point within the trajectory were applied in the
formula [1/N NΣi¼0(ri(t)–ri(0))2] to calculate mean squared displa-
cement (MSD). This formula takes into account the vector distance,
ri(t)ri(0), that is traveled by particle i over a time interval of length
t, and the squared magnitude of this vector is averaged over many
such time intervals. This quantity was further averaged for all
particles considered (N¼20 for each group of untreated and
nocodazole-treated cells), summing i from 1 to N and dividing by
N. A plot of MSD as a function of time interval was then separated
into different phases based on changes in the trend of the graph
(Forest et al., 2005). Transformation of this graph to log–log scale,
and subsequent calculation of the slope of the line of each phase
yielded a numerical value that provides information about the type
of particle movement. Slopes equal to 1, 41 or o1 represent
Brownian motion, directed or hindered movement, respectively
(Forest et al., 2005).
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